Navigation Links
Veracity Logic and Medrio Announce Real Time Interface
Date:10/31/2013

Research Triangle Park, NC and San Francisco, CA (PRWEB) October 31, 2013

Veracity Logic, a provider of interactive web and voice technology solutions (IVR/IWR) for clinical trial management, and Medrio, a leading provider of Electronic Data Capture and eClinical Tools, jointly announce the completion of a real time web services interface between their two eClinical platforms.

“We are pleased to partner with Medrio in building this real time web services interface between our products. This interface will create a seamless experience for our users. When clinical data is added or updated in either the Veracity Logic VLIRT™ system or the Medrio EDC system, the two systems will stay synchronized in real time. By having users enter data in only one system, we reduce data entry errors and end-of-study data reconciliation requirements,” said David Goldston, Managing Director of Veracity Logic (VL)."

“Medrio is excited to develop this relationship with Veracity Logic given the complementary nature of our products and the benefits to our eClinical users. This interface provides better data faster and simplifies the work for our customers,” said Scott Weidley, Sr. Director of Sales and Marketing at Medrio.

About Veracity Logic
Veracity Logic is a provider of software systems for clinical study management including interactive web and voice response technology (IVR/IWR) used to manage randomization, clinical supply inventory, and subject diaries or electronic patient reported outcomes. Founded in 2005, Veracity Logic is located in Research Triangle Park, NC. Additional information on Veracity Logic is available at http://www.veracitylogic.com.

About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies.Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit http://www.medrio.com.

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/eClinicaltools/prweb11278546.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
2. Breakthrough in study of aluminum should yield new technological advances
3. Samsung BioLogics unterzeichnet strategische Herstellungspartnerschaft mit Roche
4. Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting
5. Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
6. MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting
7. Elseviers Geofacets Adds More Than 80,000 Maps in Collaboration with The Geological Society of America
8. Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
9. New multifunctional topological insulator material with combined superconductivity
10. Market Study MBT - The European Market for Mechanical Biological Treatment Plants
11. Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... 10, 2017 , ... For the second time in three ... Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October ... US2020’s mission is to change the trajectory of STEM education in America by ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):